Podophyllum Resin Topical Tincture — FDA Drug Shortage
The FDA lists a drug shortage record for Podophyllum Resin Topical Tincture from Padagis US LLC with status To Be Discontinued. The shortage was first posted on Jul 23, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Padagis US LLC
- Package NDC
- 0574-0601-15
- Presentation
- Podocon 25, Topical Tincture, 1 mg/4 mL (NDC 0574-0601-15)
- Initial Posting
- Jul 23, 2026